{"id":82185,"date":"2017-07-04T08:30:12","date_gmt":"2017-07-04T08:30:12","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=c1dab2bf649a386c83ea2efba19aa50d"},"modified":"2017-07-04T08:30:12","modified_gmt":"2017-07-04T08:30:12","slug":"news-story-miniature-pump-for-failing-heart-to-be-trialled-with-50-patients","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=82185","title":{"rendered":"News story: Miniature pump for failing heart to be trialled with 50 patients"},"content":{"rendered":"<div class=\"govspeak\">\n<p><a rel=\"external\" href=\"http:\/\/www.caloncardio.com\/\">Calon Cardio-Technology<\/a> is preparing the UK\u2019s first artificial heart pump for a 50-patient clinical trial in 2018.<\/p>\n<p>The pioneering medical technology spin-out from <a rel=\"external\" href=\"http:\/\/www.swansea.ac.uk\/\">Swansea University<\/a>, based in the <a rel=\"external\" href=\"http:\/\/www.swansea.ac.uk\/campus-development\/phase1-completed\/singletonparkcampus\/keybuildings\/instituteoflifescience2\/\">Institute of Life Science 2<\/a>, has developed a miniaturised ventricular assist device (VAD) to be implanted directly into the left ventricle of a failing heart. This follows support from Finance Wales and Innovate UK.<\/p>\n<div class=\"call-to-action\">\n<p><a href=\"https:\/\/www.gov.uk\/government\/collections\/innovate-uk-health-and-life-sciences\">Find out more about Innovate UK\u2019s work in health and life sciences.<\/a><\/p>\n<\/div>\n<h2 id=\"dramatic-impact-on-the-quality-of-life\">Dramatic impact on the quality of life<\/h2>\n<p>Up to 60,000 new cases of advanced chronic heart failure are diagnosed every year in the UK, and 40% of those diagnosed die within 12 months.<\/p>\n<p>Calon Cardio\u2019s MiniVAD assists the weakened heart rather than replacing it. It could have a dramatic impact on quality of life for a significant number of patients.<\/p>\n<p>It can slow or stall heart failure progression and prolong the life of patients waiting for a heart transplant. The MiniVAD is driven by an embedded electric motor and is powered by a battery pack worn by the user.<\/p>\n<h2 id=\"smaller-lighter-and-more-cost-effective\">Smaller, lighter and more cost-effective<\/h2>\n<p>Existing VADs on the market are expensive, require extensive surgery for implantation and have been known to cause complications by damaging proteins and cells in the blood.<\/p>\n<p>The MiniVAD addresses these problems with a smaller, lighter pump that requires less invasive surgery and causes less damage to the blood by allowing it to flow more gently. This also means it is more cost effective.<\/p>\n<p>Innovate UK awarded Calon Cardio and Swansea University a Biomedical Catalyst grant of \u00a31.66 million in 2013, to gather the necessary performance and safety data before applying to begin human clinical studies.<\/p>\n<div class=\"call-to-action\">\n<p><a href=\"https:\/\/www.gov.uk\/government\/collections\/innovate-uk-case-studies\">See how other businesses have benefited from our support.<\/a><\/p>\n<\/div>\n<h2 id=\"substantial-benefits-to-patients\">Substantial benefits to patients<\/h2>\n<p>Stuart McConchie, Chief Executive of Calon Cardio, said it was the most-advanced pump of its kind, adding:<\/p>\n<blockquote>\n<p>This is for a very sick group of people and there are millions of them in the world, and hundreds of thousands in the UK.<\/p>\n<p>It is the first British pump to be built for this purpose: to treat blood which is flowing through the pump extremely gently and to minimise damage to the blood.<\/p>\n<p class=\"last-child\">Patients don\u2019t have return to hospital for correction of adverse events related to blood handing, so the absolute cost benefit becomes substantial.<\/p>\n<\/blockquote>\n<div class=\"call-to-action\">\n<p><a href=\"https:\/\/www.gov.uk\/apply-funding-innovation\">Apply for innovation funding.<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Calon Cardio prepares to run human trials for a more cost-effective, low-weight device, developed with support from Innovate UK.<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"_links":{"self":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/82185"}],"collection":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=82185"}],"version-history":[{"count":0,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/82185\/revisions"}],"wp:attachment":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=82185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=82185"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=82185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}